Zymeworks Inc
Change company Symbol lookup
Select an option...
ZYME Zymeworks Inc
H Hyatt Hotels Corp
ACEL Accel Entertainment Inc
USLM United States Lime & Minerals Inc
BWEN Broadwind Inc
EQIX Equinix Inc
TXMD TherapeuticsMD Inc
ORC Orchid Island Capital Inc
GBX Greenbrier Companies Inc
FCX Freeport-McMoRan Inc
Go

Health Care : Biotechnology | Small Cap Value
Based in Canada
Company profile

Zymeworks Inc. is a clinical-stage biopharmaceutical company that is engaged in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer. Its lead product candidate is zanidatamab, a bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2). Its product candidate ZW49, combines the design of zanidatamab with its ZymeLink ADC platform, comprised of its cytotoxin and cleavable linker. The Company operates through a number of platforms, including Azymetric, ZymeLink, EFECT and ProTECT. Its Azymetric is a bispecific platform that enables therapeutic antibodies to simultaneously bind multiple distinct locations on a target or to multiple targets. Its ZymeLink, which is an antibody-drug conjugate (ADC) platform comprised of cytotoxins and the linker technology used to couple these cytotoxins to tumor-targeting antibodies or proteins.

Postmarket

Last Trade
Delayed
$6.86
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$6.86
Day's Change
0.13 (1.93%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.95
Day's Low
6.72
Volume
(Light)
Volume:
467,415

10-day average volume:
967,209
467,415
  • Prev Close
    6.73
  • Today's Open
    6.87
  • Day's Range
    6.72-6.95
  • Avg Vol (10-day)
    967.2K
  • Last (time)
    4:10p ET 08/10/22
  • Last (size)
    13
  • 52-Wk Range
    4.56 - 37.19
    LowHigh
  • (09/17/21 - 04/28/22)
    50.44%
  • 80.4%
  • Market Cap
    397.1M
  • Shares Outstanding
    57.9M
  • -4.09
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.1
  • 85.26
  • (% of float 07/15/22)
    23.81

Latest News

August 04, 2022
4:15 pm ET
BusinessWire
August 01, 2022
8:30 am ET
BusinessWire
July 25, 2022
8:30 am ET
BusinessWire
July 22, 2022
8:30 am ET
BusinessWire
July 21, 2022
8:30 am ET
BusinessWire
July 15, 2022
8:00 am ET
BusinessWire
June 27, 2022
8:30 am ET
BusinessWire
June 10, 2022
9:15 am ET
BusinessWire
May 29, 2022
8:54 am ET
MarketWatch
May 27, 2022
8:30 am ET
PR Newswire
5:30 am ET
BusinessWire
May 26, 2022
5:00 pm ET
BusinessWire
May 20, 2022
9:53 am ET
MarketWatch
9:15 am ET
BusinessWire
May 19, 2022
1:01 pm ET
PR Newswire
April 13, 2022
7:06 am ET
MarketWatch
March 15, 2022
6:59 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.